Skip to main content
All lobbying filings

INNOVATIVE FEDERAL STRATEGIES, LLC

Lobbying for X-BIOTIX THERAPEUTICS, INC. · biotechnology company

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 1
  • HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 2
  • HR 5304
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
  • S 2587
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
 Lobbying activity 1
Budget/Appropriations

H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Title II, all provisions related to Antimicrobial Resistance.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem